Iterum Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.96; its P/E ratio is -0.53; Iterum Therapeutics is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $-0.72. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -12.06M	$ -9.77M	$ -5.07M	$ -29.04M	$ -5.63M
EBITDA	$ -11.03M	$ -8.75M	$ -4.22M	$ -28.59M	$ -5.17M
Net Income Common Stockholders	$ -12.24M	$ -9.67M	$ -5.44M	$ -29.11M	$ -6.74M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 44.73M	$ 51.82M	$ 60.80M	$ 64.36M	$ 68.91M
Total Assets	$ 51.02M	$ 58.12M	$ 66.83M	$ 71.56M	$ 76.69M
Total Debt	$ 11.67M	$ 10.88M	$ 10.09M	$ 30.21M	$ 23.57M
Net Debt	$ -33.07M	$ -40.95M	$ -50.71M	$ -34.14M	$ -45.34M
Total Liabilities	$ 43.89M	$ 39.16M	$ 38.83M	$ 39.01M	$ 32.80M
Stockholders Equity	$ 7.13M	$ 18.96M	$ 28.00M	$ 32.55M	$ 43.89M
Cash Flow	-
Free Cash Flow	$ -7.65M	$ -9.59M	$ -4.31M	$ -4.55M	$ -6.27M
Operating Cash Flow	$ -7.63M	$ -9.59M	$ -4.26M	$ -4.54M	$ -6.26M
Investing Cash Flow	$ 4.35M	$ 5.11M	$ 4.38M	$ 15.85M	$ -15.86M
Financing Cash Flow	$ 200.00K	$ 235.00K	$ 433.00K	$ 0.00	$ 0.00

Currency in USD

Iterum Therapeutics Earnings and Revenue History

Income Statement >

Iterum Therapeutics Debt to Assets

Balance Sheet >

Iterum Therapeutics Cash Flow

Cash Flow >

Iterum Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing